http://pharmalicensing.com/rss/ Latest market and business intelligence from the leading publishers worldwide. en-us http://pharmalicensing.com/rss/ http://pharmalicensing.com/images/pharmalicensing_logo.gif 144 BOTHELL, WA, November 12, 2009 -- MDRNA, Inc. (NASDAQ: MRNA) today reported financial results for the three- and nine-month periods ended September 30, 2009. Net loss for the third quarter of 2009... http://pharmalicensing.com/redirs/news_rss//public/news/view/499912/3/0/mdrna-inc-announces-third-quarter-2009-financial-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499912/3/0/mdrna-inc-announces-third-quarter-2009-financial-results SAN DIEGO, Calif., November 12, 2009 -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities... http://pharmalicensing.com/redirs/news_rss//public/news/view/499916/3/0/medicinova-reports-third-quarter-2009-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499916/3/0/medicinova-reports-third-quarter-2009-results FORT LEE, N.J.-- November 12, 2009-- Neurologix, Inc. (OTCBB: NRGX) (the "Company"), a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous... http://pharmalicensing.com/redirs/news_rss//public/news/view/499901/3/0/neurologix-announces-third-quarter-2009-financial-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499901/3/0/neurologix-announces-third-quarter-2009-financial-results AVAL, QC, November 12, 2009 - LAB Research Inc. ("LAB Research" or the "Company") (TSX: LRI), a global Canadian-based non-clinical contract research organization, today announced its 2009 third... http://pharmalicensing.com/redirs/news_rss//public/news/view/499905/3/0/lab-research-announces-its-2009-third-quarter-financial-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499905/3/0/lab-research-announces-its-2009-third-quarter-financial-results SAN MATEO, CA, November 12, 2009 -- Nile Therapeutics, Inc. (NASDAQ: NLTX), a company focused on the development of novel therapeutics for heart failure patients, today announced its third quarter... http://pharmalicensing.com/redirs/news_rss//public/news/view/499906/3/0/nile-therapeutics-reports-2009-third-quarter-financial-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499906/3/0/nile-therapeutics-reports-2009-third-quarter-financial-results EDMONTON, November 11, 2009 - Isotechnika Pharma Inc. (TSX:ISA) today announced its financial results for the third quarter ended September 30, 2009. http://pharmalicensing.com/redirs/news_rss//public/news/view/499764/3/0/isotechnika-pharma-reports-third-quarter-2009-financial-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499764/3/0/isotechnika-pharma-reports-third-quarter-2009-financial-results ALAMEDA, Calif.-- November 11, 2009-- InSite Vision Incorporated (OTCBB: INSV) today reported financial results for the quarter ended September 30, 2009. Total revenue for the third quarter of 2009... http://pharmalicensing.com/redirs/news_rss//public/news/view/499766/3/0/insite-vision-reports-third-quarter-2009-financial-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499766/3/0/insite-vision-reports-third-quarter-2009-financial-results TORONTO, CANADA (November 11, 2009): GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management,... http://pharmalicensing.com/redirs/news_rss//public/news/view/499786/3/0/genenews-announces-third-quarter-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499786/3/0/genenews-announces-third-quarter-results SAN MARCOS, Calif., November 11, 2009 -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today... http://pharmalicensing.com/redirs/news_rss//public/news/view/499718/3/0/natural-alternatives-international-inc-announces-fiscal-2010-q1-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499718/3/0/natural-alternatives-international-inc-announces-fiscal-2010-q1-results Salt Lake City, Utah (November 11, 2009) - Dynatronics Corporation (NASDAQ: DYNT) plans to release financial results for its quarter ended September 30, 2009 during the morning of Friday, November... http://pharmalicensing.com/redirs/news_rss//public/news/view/499723/3/0/dynatronics-to-release-first-quarter-results http://pharmalicensing.com/redirs/news_rss//public/news/view/499723/3/0/dynatronics-to-release-first-quarter-results